News

GSK will invest $30 billion in U.S. R&D and manufacturing, including a new biologics factory, AI upgrades, and expanded drug ...
British drugmaker GSK Plc pledged to invest $30 billion in the US over the next five years, making the announcement as ...
Investors in GSK plc (Symbol: GSK) saw new options begin trading today, for the December 29th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GSK options chain ...
GSK plc GSK is one of the key vaccine makers in the world, marketing vaccines to help prevent infectious diseases like Respiratory Syncytial Virus or RSV, meningitis, shingles, hepatitis and many more ...
Investors with a lot of money to spend have taken a bearish stance on GSK (NYSE:GSK). And retail traders should know. We noticed this today when the positions showed up on publicly available options ...
GSK PLC (NYSE:GSK) shares ended its trading session in the green for seventh consecutive day on Wednesday. The stock closed up 0.65% at $42.02. GSK is up 12.7% YTD, compared to the broader S&P 500, ...
GSK (LON:GSK – Get Free Report)‘s stock had its “hold” rating reiterated by Berenberg Bank in a research report issued on Friday, MarketBeat.com reports. They presently have a GBX 1,600 ($21.48) ...
WVE-006 produces AAT protein at disease-protective levels in all treated patients. The monthly dosing regimen is under study, with more data expected in Q1 2026. See the trading strategy with a ...
GSK PLC GSK shares slid 1.63% to £14.79 Monday, on what proved to be an all-around poor trading session for the stock market, ...
Health-care companies ticked up on renewed hopes about the sector's growth prospects. Eli Lilly rose after the maker of obesity drugs said new data from its late-stage trial of its investigational ...
NEW YORK, March 21, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMD, AMZN, INTC, GSK, and VKTX. Click a link below then choose between in-depth options trade idea ...
LON:GSK opened at GBX 1,429 ($18.05) on Friday. The company has a debt-to-equity ratio of 114.64, a quick ratio of 0.73 and a current ratio of 0.81. The firm has a market cap of £57.99 billion, a ...